A Trial to Evaluate Epothilone D in Patients With Advanced Solid Tumors

NCT00030173 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: Epothilone D (KOS-862)

Sponsor

Bristol-Myers Squibb